Impact of type 2 diabetes on malignancies of the female reproductive system
Molecular Aspects of Medicine · 2026
DOI: 10.1016/j.mam.2026.101459 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Aspects of Medicine, 2026. Verfasst von Cristian Espinoza und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Center for Cancer prevention and…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Genital Neoplasms, Female. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 331 Literaturangaben. Gefördert von: Millennium Institute on Immunology and Immunotherapy, Fondo Nacional de Desarrollo Científico y Tecnológico, Agencia Nacional de Investigación y Desarrollo.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) contributes significantly to the development and progression of cancers of the female reproductive tissues, particularly endometrial, ovarian, and breast. Hallmarks of T2DM, such as hyperinsulinemia, insulin resistance, and chronic low-grade inflammation, disrupt endocrine and metabolic homeostasis, promoting carcinogenesis through enhanced mitogenic signaling, hormonal dysregulation, and immune activation. T2DM can alter ovarian, endometrial, and mammary physiology by affecting estrogen/progesterone receptor activity, stromal remodeling, and specialized cell function. Furthermore, give the fluctuations in a woman's hormonal levels and reproductive status, the presence of excess weight and T2DM may have altering risks depending on the lifecycle. These effects are exacerbated by adipose-derived cytokines and leptin resistance, further amplifying estrogens' bioavailability and pro-inflammatory signaling. Endometrial cancer risk is nearly doubled in diabetic women, independent of body mass index, with hyperglycemia inducing PI3K/AKT/mTOR and NF-κB pathway activation, reduced sex hormone-binding globulin (SHBG) levels, and upregulation of estrogen receptor signaling. Ovarian cancer in diabetic patients is associated with more aggressive histological subtypes, advanced-stage presentation, and poorer survival, likely driven by Insulin-like growth factor 1 (IGF-1) signaling, oxidative stress, and impaired treatment response. Similarly, T2DM increases the risk and worsens outcomes in breast cancer via enhanced expression, AGE-RAGE interactions, and estrogen-independent ERα activation. Herein, we synthesize current epidemiological evidence and mechanistic insights to delineate the multifaceted relationship between T2DM and these cancers. Despite increased risk, diabetic women often face underdiagnosis due to suboptimal screening practices. As T2DM prevalence rises globally, tailored cancer prevention and treatment strategies for diabetic populations are urgently needed. Metformin has shown robust benefits in reducing T2DM-related complications and potential in the antineoplastic setting. This review underscores the endocrine and inflammatory mechanisms linking T2DM to cancers of the female reproductive system and advocates for integrated clinical protocols that include early screening and individualized management in diabetic women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Center for Cancer prevention and Control (FONDAP-CECAN), Pontificia Universidad Católica de Chile), Sa…
- Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Hematology and Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile,…
Förderung
- Millennium Institute on Immunology and Immunotherapy
- Fondo Nacional de Desarrollo Científico y Tecnológico
- Agencia Nacional de Investigación y Desarrollo
Zitieren
APA
Espinoza, C., Veas-Torres, J., Miranda, D. I., & Owen, G. I. (2026). Impact of type 2 diabetes on malignancies of the female reproductive system. Molecular Aspects of Medicine. https://doi.org/10.1016/j.mam.2026.101459
Vancouver
Espinoza C, Veas-Torres J, Miranda DI, Owen GI. Impact of type 2 diabetes on malignancies of the female reproductive system. Molecular Aspects of Medicine. 2026. doi:10.1016/j.mam.2026.101459
BibTeX
@article{Espinoza2026,
author = {Espinoza, Cristian and Veas-Torres, Javiera and Miranda, Daniela I and Owen, Gareth I},
title = {Impact of type 2 diabetes on malignancies of the female reproductive system},
journal = {Molecular Aspects of Medicine},
year = {2026},
doi = {10.1016/j.mam.2026.101459}
}
EUVIMED